Ms. Teri Loxam's most recent trade in Vaxcyte Inc was a trade of 11,389 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | 15 Jun 2026 | 11,389 | 11,389 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 2,265 | 12,481 | - | 0 | Common Stock | |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | 26 Mar 2026 | 157,635 | 157,635 | - | - | Share Option (Right to Buy) | ||
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 75,000 | 152,002 | - | 0 | Ordinary Shares | |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.89 per share. | 11 Mar 2026 | 1,781 | 77,002 | - | 6.9 | 12,271 | Ordinary Shares |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.02 per share. | 02 Mar 2026 | 4,467 | 78,783 | - | 7.0 | 31,358 | Ordinary Shares |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 10,216 | - | 0 | Common Stock | |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 10,216 | - | 0 | - | |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | 11 Mar 2025 | 76,000 | 76,000 | - | - | Share Option (Right to Buy) | ||
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 25,000 | 83,250 | - | 0 | Ordinary Shares | |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam, M.B.A. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.67 per share. | 03 Mar 2025 | 4,468 | 58,250 | - | 3.7 | 16,398 | Ordinary Shares |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | 15 Jan 2025 | 6,250 | 6,250 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 15 Jan 2025 | 6,250 | 13,425 | - | 22.7 | 141,875 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 15 Jan 2025 | 6,250 | 13,425 | - | 22.7 | 141,875 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 83.93 per share. | 15 Jan 2025 | 1,202 | 10,726 | - | 83.9 | 100,885 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 83.93 per share. | 15 Jan 2025 | 1,202 | 10,726 | - | 83.9 | 100,885 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 82.89 per share. | 15 Jan 2025 | 1,136 | 11,928 | - | 82.9 | 94,168 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 82.89 per share. | 15 Jan 2025 | 1,136 | 11,928 | - | 82.9 | 94,168 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 85.29 per share. | 15 Jan 2025 | 1,043 | 9,683 | - | 85.3 | 88,961 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 85.29 per share. | 15 Jan 2025 | 1,043 | 9,683 | - | 85.3 | 88,961 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 87.38 per share. | 15 Jan 2025 | 1,013 | 7,704 | - | 87.4 | 88,513 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 87.38 per share. | 15 Jan 2025 | 1,013 | 7,704 | - | 87.4 | 88,513 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 86.26 per share. | 15 Jan 2025 | 966 | 8,717 | - | 86.3 | 83,324 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 86.26 per share. | 15 Jan 2025 | 966 | 8,717 | - | 86.3 | 83,324 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 88.54 per share. | 15 Jan 2025 | 529 | 7,175 | - | 88.5 | 46,836 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 88.54 per share. | 15 Jan 2025 | 529 | 7,175 | - | 88.5 | 46,836 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 15 Jan 2025 | 215 | 13,064 | - | 81.5 | 17,530 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 15 Jan 2025 | 215 | 13,064 | - | 81.5 | 17,530 | - |
| Vaxcyte Inc | Ms. Teri Loxam, M.B.A. | Director | Sale of securities on an exchange or to another person at price $ 80.46 per share. | 15 Jan 2025 | 146 | 13,279 | - | 80.5 | 11,747 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 80.46 per share. | 15 Jan 2025 | 146 | 13,279 | - | 80.5 | 11,747 | - |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 17 Sep 2024 | 6,250 | 13,425 | - | 22.7 | 141,875 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | 17 Sep 2024 | 6,250 | 12,500 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 116.62 per share. | 17 Sep 2024 | 4,308 | 7,431 | - | 116.6 | 502,387 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 115.32 per share. | 17 Sep 2024 | 1,445 | 11,739 | - | 115.3 | 166,634 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 117.51 per share. | 17 Sep 2024 | 256 | 7,175 | - | 117.5 | 30,083 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 114.64 per share. | 17 Sep 2024 | 241 | 13,184 | - | 114.6 | 27,628 | Common Stock |
| Vaxcyte Inc | Ms. Teri Loxam | Director | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 7,175 | - | 0 | Common Stock | |
| Compass Pathways PLC (ADR) | Ms. Teri Loxam | Chief Financial Officer | 01 Mar 2024 | 117,643 | 117,643 | - | - | Share Option (Right to Buy) | ||
| Compass Pathways PLC (ADR) | Ms. Teri Loxam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 62,718 | 62,718 | - | 0 | Ordinary Shares | |
| Vaxcyte Inc | Ms. Teri Loxam | Director | 13 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Vaxcyte Inc | Ms. Teri Loxam | Director | 01 Jun 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | ||
| Vaxcyte Inc | Ms. Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,125 | 3,125 | - | 0 | Common Stock |